NVIDIA AI Factory, Berkshire Deal, and Anthropic Files for IPO

NVIDIA took the Computex stage on Monday, and the AI trade got its latest shot of enthusiasm.

The company unveiled its Vera Rubin AI factory reference architecture alongside Siemens, named Fluence Energy as the battery storage partner, and described its new superchip as the most efficient PC chip ever built.

Oil surged on new Iran clashes while Anthropic filed for an IPO and Berkshire made its first major acquisition under Greg Abel. Today's edition has everything.

While the rest of the market goes crazy for "the mother of all IPOs", a new Elon Musk innovation is quietly being rolled out nationwide.

It's been 27 years in the making, and it could have a radical impact on how millions of people manage their money… and even collect Social Security.

Here's everything you need to know.

*This ad is sent on behalf of InvestorPlace Media at 1125 N. Charles Street, Baltimore, Maryland 21201. If you're not interested in this opportunity, please click here.

One rare earths CEO sold more than $26.2 million after a 215% one-year run, while the CEO of a travel platform sold another $68.4 million near the stock’s upper range. You’re seeing two familiar growth stories. Insider readers are seeing where the people at the top are using strength to cash out while the market is still debating the next leg.

Every day, insiders and institutions move millions before the market catches on. We surface the data behind those moves before the rest of the market sees it.

A subscription gets you:

$25/mo or $250/yr. 30-day money back guarantee. Cancel anytime. Founding member pricing: lock in $25/mo before we raise it.

NVIDIA unveiled its Vera Rubin AI factory reference architecture at Computex alongside Siemens, naming Fluence Energy as the official battery storage partner and describing a blueprint designed to help hyperscalers deploy large-scale AI infrastructure in power-constrained environments.

Oil surged back toward $94 on new Iran-U.S. clashes in the Strait of Hormuz, erasing a significant portion of last week's decline that had been driven by peace talk optimism.

Berkshire Hathaway announced a $6.8 billion acquisition of homebuilder Taylor Morrison, Greg Abel's first major deal as CEO succeeding Warren Buffett, while Anthropic filed confidentially for an IPO at a reported valuation near $965 billion.

ARM Holdings jumped after Nvidia named it a key partner for its new AI laptop push alongside Dell, HP, and Microsoft.

IBM (NYSE: IBM) just received a major outside validation of the company it has been trying to become.

Barclays launched coverage with a bullish view, pointing to IBM’s shift toward software, hybrid cloud, AI-driven enterprise demand, and long-term margin strength.

For years, IBM was often viewed as a legacy name trying to stay relevant.

Now the story is moving toward a company built around software, enterprise infrastructure, and long-term relationships with large regulated customers.

Old IBM Is Not the Story Anymore

IBM’s software business is now becoming the center of the company.

That matters because software brings stronger recurring demand, better profitability, and deeper customer lock-in than older hardware-heavy models.

Even if you never follow enterprise software closely, the business point is simple. IBM is becoming more valuable as it moves toward the technologies companies depend on every day.

Red Hat Is Doing Real Work

IBM’s hybrid cloud strategy is built heavily around Red Hat, its open-source software arm.

Red Hat helps companies run applications across public and private clouds and their own internal systems, making IBM more useful to businesses that cannot move everything into a single place.

For companies dealing with complex operations, you want partners that reduce risk, not just promise new features.

IBM is leaning into that role, and that is why this update feels like a real company moment rather than just another analyst call.

Moderna (NASDAQ: MRNA) just became part of a major global health push to develop a vaccine against Ebola Bundibugyo, a deadly strain with no approved vaccine or treatment.

CEPI is backing Moderna’s vaccine candidate as health agencies work to respond to a serious outbreak in Congo and Uganda.

For Moderna, this is bigger than one vaccine program.

The company has been trying to prove its vaccine platform can matter beyond COVID, and Ebola gives it a high-urgency test in an area where the world badly needs faster medical tools.

A New Test for Moderna’s Platform

Moderna built its name on speed during the pandemic.

Now the company has a chance to show that the same model can be used against another dangerous disease, especially one where approved options do not exist.

You can see the business importance here. Moderna is being pulled into a global health emergency where speed, manufacturing readiness, and clinical execution all matter.

Ebola Gives Moderna a Bigger Stage

Ebola Bundibugyo is not a routine disease target.

It is dangerous, hard to contain, and urgent enough to bring global health organizations, governments, and vaccine developers into the same fight.

That puts Moderna in a serious position. A successful program would strengthen your read on the company as more than a pandemic-era vaccine name.

The company now has a chance to prove itself in a more challenging global health environment.

If progress comes quickly, you get Moderna moving closer to the role it wants: a vaccine company built for urgent outbreaks and future pandemic preparedness.

Bloomberg is calling Elon Musk's upcoming SpaceX IPO "the biggest listing of ALL TIME."

But here's the thing - most investors will be locked out until AFTER it goes public.

Not you.

I've found a 'backdoor' that lets everyday Americans grab a pre-IPO stake in SpaceX right now.

Click Here for the FREE "SpaceX" Ticker

Motorola Solutions just acquired Israeli startup D-Fend Solutions for $1.5 billion.

D-Fend makes technology that uses radio waves to take over rogue drones mid-flight and land them safely. No jamming. No shooting. Just control.

The system is already deployed in over 30 countries and used by the U.S. Homeland Security, Defense, and Justice departments.

Last year, Motorola spent $4.4 billion on drone communications. Now it owns the anti-drone side too. That is both sides of the sky under one roof.

The Drone Threat Is Not Theoretical

Attacks on data centers, airport shutdowns across Europe, and military conflicts have made rogue drones one of the most urgent security challenges in the world.

New U.S. law now allows local police to actively intercept unauthorized drones. That created a brand new market overnight.

An $8 Billion Market by 2031

The anti-drone industry is projected to more than triple in the next five years. D-Fend's revenue has grown over 50% annually for three straight years.

Motorola is buying into a category with massive tailwinds and almost no slowdown in sight.

This deal changes your entire understanding of what Motorola Solutions does. It is no longer the company that makes walkie-talkies for first responders.

It is becoming the platform that protects critical infrastructure from threats most people have not even thought about yet.

You build radios, then communications networks, then drone systems, then anti-drone defenses, and suddenly, a company most people overlooked is sitting at the center of modern security.

Fluence Energy [FLNC] $27.15 (+43.80%)

NVIDIA named Fluence Energy as the official battery storage partner in its new Vera Rubin AI factory reference architecture, developed alongside Siemens.

Fluence's Smartstack platform will provide grid support and power management for AI data centers operating in power-constrained environments.

With a $5.6 billion order backlog and hyperscaler supply agreements already signed, this wasn't just a logo placement.

It was a product architecture commitment from the most important company in AI infrastructure.

Taylor Morrison [TMHC] $71.55 (+22.31%)

Berkshire Hathaway announced a $6.8 billion all-cash acquisition of Taylor Morrison, one of Greg Abel's first major strategic moves since taking over as CEO from Warren Buffett in January.

The deal puts a hard floor under the stock at the acquisition price and confirms that Berkshire's new leadership sees homebuilding as a durable bet despite elevated mortgage rates.

Shareholders basically woke up on Monday with a very certain outcome.

Elmet Group [ELMT] $18.88 (+23.57%)

The Elmet Group produces specialty tungsten and molybdenum components for defense electronics, semiconductor fabrication equipment, and medical imaging applications.

Running on the dual tailwind of defense procurement acceleration driven by the Iran war and AI chip manufacturing demand for refractory metals used in high-precision deposition and etching processes.

The $572 million Strong Buy-rated company is quietly positioned at the intersection of two of 2026's most powerful spending themes.

Rocket Lab [RKLB] $122.39 (-14.70%)

Rocket Lab fell on a combination of negative space sector sentiment following Blue Origin's recent launch failure and straight-up profit-taking after the stock had been on an extraordinary run.

Analysts also pushed out AST SpaceMobile coverage timelines to 2028, weighing on the broader commercial space trade.

At a $70.85 billion Strong Buy-rated market cap and no new negative company news, this is a momentum correction in a name that had gotten very expensive very fast.

Nuvalent [NUVL] $93.01 (-15.74%)

Nuvalent is a precision oncology biotech with a Strong Buy consensus and legitimate clinical momentum in ROS1 and ALK cancer treatment.

The drop is sector rotation as oil's resurgence brought a risk-off tone to high-multiple clinical biotech names, rather than anything wrong with the company.

When crude jumps and inflation fears return, speculative biotech premiums are usually the first thing to compress.

Redwire [RDW] $20.68 (-15.83%)

Redwire was downgraded by an analyst on valuation concerns after the space infrastructure company's stock ran hard on defense and space sector momentum.

The $4.11 billion Buy-rated company's 12-month consensus target of $15.67 is now well below the current price, which is the market's polite way of saying the easy money has been made and the remaining upside requires execution that the company hasn't delivered yet.

Tensions in Iran are escalating, not cooling down. Airstrikes continue, oil routes are under pressure, and analysts warn the economic fallout could deepen.

Gas prices are already climbing. Inflation could spike again. And portfolios heavy in stocks and bonds may be exposed if this situation worsens.

That's why many Americans are moving a portion of their retirement savings into physical gold — an asset that historically holds value during periods of conflict and uncertainty.

Red State Gold Group's FREE Gold IRA Guide shows how eligible IRA or 401(k) funds can be rolled into physical gold and silver.

Get your free guide today.

Or call (888) 711-2433 for more information.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.